about
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaSide effects of yttrium-90 radioembolizationCancer concepts and principles: primer for the interventional oncologist-part ICancer concepts and principles: primer for the interventional oncologist-part IIIncreased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With ChemoembolizationY90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaDiffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization.MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study.Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumorsJOURNAL CLUB: Four-Dimensional Flow MRI-Based Splenic Flow Index for Predicting Cirrhosis-Associated Hypersplenism.Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumorsRadiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolizationQuality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinomaRole of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlationTrans-arterial hepatic radioembolisation of yttrium-90 microspheres.Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.Research reporting standards for radioembolization of hepatic malignancies.Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinomaQuantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints.Radioembolization for primary and metastatic liver cancer.Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesExtrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.Complications of renal transplantation.Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
P50
Q26753089-8B116E79-0DC3-4830-9B5A-EF978C9C2E34Q26821887-BF7E0DEE-E6C6-4548-BEEC-966C4720B093Q26851255-97293D4A-4FEC-45C7-AF52-E975C5F5A423Q27010961-60D8CC1D-1BE9-4F70-869F-8F83F8687195Q28111719-99C1367F-17E3-4607-83C6-E68B9737E1CEQ28314897-3E44362E-C38B-4817-86BA-FAD8C8B69B24Q31049725-DB7A4510-6C29-4738-8EBF-CCC4AD9B8773Q33374481-D2F25707-4131-42B4-8A48-9D710A1A6264Q33376925-87D747BC-B1AE-40AC-B97F-FFD537168C8AQ33441535-38B35967-247A-4EC6-A195-06335DFCC39AQ33532957-F050F91E-74C7-44B7-A20F-5F7033F731EDQ33576048-0437E013-39C1-45EA-B983-7E373BE7485BQ34065098-64167AD5-1D9B-4B12-AB46-40CF8D038F17Q34143449-A675C5D0-6125-40D6-8852-D97468DD55CFQ34168811-D75F8AB0-6427-4EAA-88F1-2F62BB458A5CQ34330617-86BD7074-7DF6-4DEF-A397-534471435AD8Q34585175-51C505BC-06CD-4512-8237-898FA5101D8DQ34620919-83E2C0E4-40C4-4915-8362-CF96A92FE314Q34650742-EAD0EB83-7855-414B-9256-38808CAB9240Q34654186-FB794351-1331-4E07-81A6-C276B5041574Q34681150-43F8635E-6BBE-4CA4-96BE-D0152BD02EDBQ34702065-01008453-5C23-442C-BD57-0750B65B2FADQ34982068-E4198718-D032-446D-833E-F0E647891156Q34991390-BF0D1F51-EB22-479A-B4BB-EEDD1AFBDE20Q35051942-4931612B-E934-4052-8CDB-9C772DF2F7F8Q35111887-E9C23FF4-8DA9-4AA1-9361-99F237BFC3DBQ35154103-2072F3A6-57A9-41D2-A7EE-BDBA34BFE25DQ35168279-03E21268-0EB2-4F03-9B4B-A05E3F0D96F9Q35203257-D5C3EEF5-F191-4847-B1C0-82378A76EC6EQ35452809-D32C426A-D32A-4B25-A8BB-2513F9E568FAQ35564038-7B4D3AF3-7A29-4E30-81D4-5F3F68144838Q35815482-0506E01E-37EF-4D9E-85FC-CD1FC45880BEQ35877902-B7381C89-CF20-4C1F-8FE3-E1D1E9CFD94EQ36256371-A823E91E-B7C7-4DA5-82B1-C7BE8A2D02AFQ36258276-4EAD96B5-CA01-4D87-B5D5-EA65BDAEA788Q36481071-6C9D10B9-640A-47F9-B1C3-65A982BAEDF5Q36481678-9ADE9CCE-D682-4ABE-99B3-BB1ED36F0801Q36482781-06B32FC7-179C-47D0-97B1-EB3997820A25Q36573194-BB22C143-F19F-48B9-A911-529758E40570Q36595720-4EFA70E3-E2C7-4597-AB79-9FFBEFE837F9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Riad Salem
@ast
Riad Salem
@en
Riad Salem
@es
Riad Salem
@nl
Riad Salem
@sl
type
label
Riad Salem
@ast
Riad Salem
@en
Riad Salem
@es
Riad Salem
@nl
Riad Salem
@sl
prefLabel
Riad Salem
@ast
Riad Salem
@en
Riad Salem
@es
Riad Salem
@nl
Riad Salem
@sl
P1053
Q-3849-2017
P106
P1153
7005073491
P21
P31
P3829
P496
0000-0001-9745-1825
P569
2000-01-01T00:00:00Z